Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 09-2003 | 06-2003 | 03-2003 | 12-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,986 | -21,268 | -13,946 | -6,104 | -20,789 |
| Depreciation Amortization | 1,917 | 1,471 | 1,005 | 548 | 2,296 |
| Accounts receivable | -463 | 131 | 316 | -45 | 44 |
| Other Working Capital | -2,130 | -2,773 | -1,522 | -2,034 | -1,889 |
| Other Operating Activity | 4,241 | 2,736 | 1,711 | 970 | 3,092 |
| Operating Cash Flow | $-27,421 | $-19,703 | $-12,435 | $-6,665 | $-17,246 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -19,633 | 21,422 | 17,371 | 15,739 | 14,865 |
| PPE Investments | -1,442 | -925 | -676 | -387 | -2,220 |
| Other Investing Activity | -401 | -400 | -39 | -1 | -130 |
| Investing Cash Flow | $-21,476 | $20,097 | $16,656 | $15,351 | $12,515 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 57,669 | 1,961 | 1,186 | 499 | 1,418 |
| Other Financing Activity | -4,382 | -253 | -165 | 0 | 0 |
| Financing Cash Flow | $53,287 | $1,708 | $1,021 | $499 | $1,418 |
| Beginning Cash Position | 7,447 | 9,447 | 9,447 | 9,447 | 10,760 |
| End Cash Position | 11,837 | 11,549 | 14,689 | 18,633 | 7,447 |
| Net Cash Flow | $4,390 | $2,102 | $5,242 | $9,186 | $-3,313 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,421 | -19,703 | -12,435 | -6,665 | -17,246 |
| Capital Expenditure | -1,442 | -925 | -676 | -387 | -2,220 |
| Free Cash Flow | -28,863 | -20,628 | -13,111 | -7,052 | -19,466 |